Advertisement

Gov't Approves First-Ever Med with Digital Tracking System

Gov't Approves First-Ever Med with Digital Tracking System

November 14, 2017 04:42 PM

WASHINGTON (AP) - The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system in an unprecedented step to ensure that patients with mental disorders take the medicine prescribed for them.

Advertisement – Content Continues Below

The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was initially approved for marketing in 2012. The agency says the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch."

Dr. Mitchell Mathis of the FDA says officials support "use of new technology in prescription drugs and is committed to working with companies to understand how the new technology might benefit patients and prescribers."


WDIO

Copyright 2017 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

Bad River Tribal Members Voice Concerns About Sheriff's Department

St. John's Catholic Church Serves Christmas Dinner

LSC Graduates Celebrate with Pinning Ceremony

UMD Professor Weighs in on Local Impacts of GOP Tax Bill

Duluth Police Say Car Thefts Spiked in 2017

Crisis Intervention Training for Range Police Officers

Advertisement